681TopLevel: Yes

PharmaBlock opens OPC R&D centre

28th September 2026

Submitted by:

Andrew Warmington

China’s PharmaBlock has officially inaugurated its new Oligonucleotide, Peptide and Conjugates (OPC) R&D centre in

Curia to scale NCT process

28th September 2026

Submitted by:

Andrew Warmington

ExoZymes, which develops AI-enhanced enzymes that transform abundant feedstock into nutraceuticals and novel medicines, will

First peptide module opens

28th September 2026

Submitted by:

Andrew Warmington

The first of four scheduled modules has begun operations at Neuland Laboratories’ commercial-scale peptide manufacturing site

Axplora expands in India

13th August 2025

Submitted by:

Andrew Warmington

Axplora has announced a “significant” investment at its site in Vizag, India (pictured)

Esteve acquires Regis

4th August 2025

Submitted by:

Andrew Warmington

 

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago, and

Ofichem buys site in Sweden

4th August 2025

Submitted by:

Andrew Warmington

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which

Nucleic acid API boost

30th June 2025

Submitted by:

Andrew Warmington

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Flamma opens in China

30th June 2025

Submitted by:

Andrew Warmington

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Subscribe to Pharmaceuticals